Lung clearance index and diffusion capacity for CO to detect early functional pulmonary impairment in children with rheumatic diseases.

Children Diffusion capacity for carbon monoxide Immunosuppressive therapy Juvenile idiopathic arthritis Lung clearance index Pulmonary impairment Rheumatic disease

Journal

Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897

Informations de publication

Date de publication:
06 Mar 2021
Historique:
received: 28 08 2020
accepted: 19 02 2021
entrez: 7 3 2021
pubmed: 8 3 2021
medline: 4 11 2021
Statut: epublish

Résumé

In adults with rheumatic diseases pulmonary complications are relevant contributors to morbidity and mortality. In these patients diffusion capacity for CO (DLCO) is an established method to detect early pulmonary impairment. Pilot studies using DLCO indicate that early functional pulmonary impairment is present even in children with rheumatic disease albeit not detectable by spirometry and without clinical signs of pulmonary disease. Since the lung clearance index (LCI) is also a non-invasive, feasible and established method to detect early functional pulmonary impairment especially in children and because it requires less cooperation (tidal breathing), we compared LCI versus DLCO (forced breathing and breath-holding manoeuvre) in children with rheumatic diseases. Nineteen patients (age 9-17 years) with rheumatic disease and no clinical signs of pulmonary disease successfully completed LCI and DLCO during annual check-up. In 2 patients LCI and DLCO were within physiological limits. By contrast, elevated LCI combined with physiological results for DLCO were seen in 8 patients and in 9 patients both, the LCI and DLCO indicate early functional pulmonary changes. Overall, LCI was more sensitive than DLCO to detect early functional pulmonary impairment (p = 0.0128). Our findings suggest that early functional pulmonary impairment is already present in children with rheumatic diseases. LCI is a very feasible and non-invasive alternative for detection of early functional pulmonary impairment in children. It is more sensitive and less cooperation dependent than DLCO. Therefore, we suggest to integrate LCI in routine follow-up of rheumatic diseases in children.

Sections du résumé

BACKGROUND BACKGROUND
In adults with rheumatic diseases pulmonary complications are relevant contributors to morbidity and mortality. In these patients diffusion capacity for CO (DLCO) is an established method to detect early pulmonary impairment. Pilot studies using DLCO indicate that early functional pulmonary impairment is present even in children with rheumatic disease albeit not detectable by spirometry and without clinical signs of pulmonary disease. Since the lung clearance index (LCI) is also a non-invasive, feasible and established method to detect early functional pulmonary impairment especially in children and because it requires less cooperation (tidal breathing), we compared LCI versus DLCO (forced breathing and breath-holding manoeuvre) in children with rheumatic diseases.
FINDINGS RESULTS
Nineteen patients (age 9-17 years) with rheumatic disease and no clinical signs of pulmonary disease successfully completed LCI and DLCO during annual check-up. In 2 patients LCI and DLCO were within physiological limits. By contrast, elevated LCI combined with physiological results for DLCO were seen in 8 patients and in 9 patients both, the LCI and DLCO indicate early functional pulmonary changes. Overall, LCI was more sensitive than DLCO to detect early functional pulmonary impairment (p = 0.0128).
CONCLUSIONS CONCLUSIONS
Our findings suggest that early functional pulmonary impairment is already present in children with rheumatic diseases. LCI is a very feasible and non-invasive alternative for detection of early functional pulmonary impairment in children. It is more sensitive and less cooperation dependent than DLCO. Therefore, we suggest to integrate LCI in routine follow-up of rheumatic diseases in children.

Identifiants

pubmed: 33676536
doi: 10.1186/s12969-021-00509-1
pii: 10.1186/s12969-021-00509-1
pmc: PMC7937245
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23

Références

Arthritis Rheumatol. 2018 Oct;70(10):1544-1554
pubmed: 29806092
Respirology. 2018 Aug;23(8):764-770
pubmed: 29573509
J Cyst Fibros. 2017 Mar;16(2):258-266
pubmed: 27919570
J Cyst Fibros. 2019 May;18(3):399-406
pubmed: 30420236
Am J Respir Crit Care Med. 1998 May;157(5 Pt 2):S181-3
pubmed: 9606316
Eur Respir J. 2017 Jan 3;49(1):
pubmed: 28049168
Pediatr Pulmonol. 2019 Aug;54(8):1242-1249
pubmed: 31099485
Eur Respir J. 2013 Mar;41(3):507-22
pubmed: 23397305
Eur Respir J. 2013 Jun;41(6):1371-7
pubmed: 23143552
Pediatr Pulmonol. 2009 Dec;44(12):1180-5
pubmed: 19911370
Paediatr Respir Rev. 2011 Dec;12(4):264-70
pubmed: 22018042
Eur Respir J. 2017 Sep 11;50(3):
pubmed: 28893868
Respir Physiol Neurobiol. 2005 Aug 25;148(1-2):125-39
pubmed: 15993657
Am J Respir Crit Care Med. 2011 Mar 15;183(6):752-8
pubmed: 20935113
Clin Exp Rheumatol. 1994 Nov-Dec;12(6):675-9
pubmed: 7895405
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Thorax. 2008 Feb;63(2):129-34
pubmed: 17675316
Arch Dis Child. 2016 Aug;101(8):752-8
pubmed: 26768831

Auteurs

Julia Hildebrandt (J)

Department of Pediatrics, Rostock University Medical Centre, Ernst-Heydemann Strasse 8, DE 18057, Rostock, Germany.

Anja Rahn (A)

Department of Pediatrics, Rostock University Medical Centre, Ernst-Heydemann Strasse 8, DE 18057, Rostock, Germany.

Anja Kessler (A)

Department of Pediatrics, Rostock University Medical Centre, Ernst-Heydemann Strasse 8, DE 18057, Rostock, Germany.

Fabian Speth (F)

Department of Pediatrics, Rostock University Medical Centre, Ernst-Heydemann Strasse 8, DE 18057, Rostock, Germany.

Dagmar-Christiane Fischer (DC)

Department of Pediatrics, Rostock University Medical Centre, Ernst-Heydemann Strasse 8, DE 18057, Rostock, Germany.

Manfred Ballmann (M)

Department of Pediatrics, Rostock University Medical Centre, Ernst-Heydemann Strasse 8, DE 18057, Rostock, Germany. Manfred.Ballmann@med.uni-rostock.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH